Xin Wang, Haihui Xiao, Yi Xu and Cheng Wang*
Volume1-Issue2
Dates: Received: 2020-05-25 | Accepted: 2020-06-12 | Published: 2020-06-12
Pages: 021-023
Abstract
Since December 2019, the outbreak of SARS-CoV-2 in WuHan, HuBei province, has spread to the whole country and abroad. As a susceptible population, the number of children and adolescents is increasing day by day. Under the severe situation of epidemic prevention and control, pediatric department has successively launched the expert consensus and treatment recommendations on the prevention and control of novel coronavirus pneumonia (COVID-19) in related fields. Syncope is a common emergency in children and adolescents, recurrent syncope seriously affects the quality of life and mental health of children. It is difficult for children with syncope to seek medical treatment during the epidemic period. This paper puts forward some Suggestions on the rehabilitation of children and adolescents with syncope during the epidemic period.
FullText HTML
FullText PDF
DOI: 10.37871/jels1115
Certificate of Publication
Copyright
© 2020 Wang X, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Wang X, Xiao H, Xu Y, Wang C. Recommendations for Individualized Rehabilitation of Syncope in Children and Adolescents during the COVID-19 Epidemic. J Biomed Res Environ Sci. 2020 Jun 12; 1(2): 021-023. DOI: 10.37871/jels1115; Article ID: jels1115
Subject area(s)
University/Institute
References
- National Health Committee of the People’s Republic of China. Diagnosis and treatment plan of novel coronavirus pneumonia.
- Wang C, Li Y, Liao Y, Hong T, Min H, Xiangyu D, et al. 2018 Chinese Pediatric Cardiology Society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescents. Sci Bull. 2018; 63: 1558-1564. DOI: https://doi.org/10.1016/j.scib.2018.09.019
- Zhang Z, Jiang X, Han L, Selena C, Ling T, Chunyan T, et al. Differential diagnostic models between vasovagal syncope and psychogenic pseudosyncope in children. Front Neurol. 2020; 10: 1392. DOI: 10.3389/fneur.2019.01392
- Pediatric syncope professional committee of pediatrician branch of Chinese medical association, functional cardiovascular assistance group of cardiovascular group of pediatric branch of Chinese medical association, child cardiovascular professional committee of cardiovascular physician branch of Chinese medical association, et al. Suggestions on the implementation of head-up tilt test in children and adolescents with syncope during the COVID-19 epidemic. Chin J Appl Clin Pediatr. 2020; 35: 130-132.
- Accurate diagnosis and treatment of cardiomyopathy in children in the cardiology group of the pediatric society of Chinese medical association, Cardiology group heart failure cooperative group of Chinese pediatric society. Clinical management suggestions for children and adolescents with chronic heart failure in the prevention and control of new coronavirus pneumonia. Chin J Appl Clin Pediatr. 2020; 35: 112-117.
- Yogasundaram H, Hung W, Paterson ID, Consolato S, Gavin YO. Chloroquine-induced cardiomyopathy: A reversible cause of heart failure. ESC Heart Fail. 2018; 5: 372-375. DOI: 10.1002/ehf2.12276
- Yogasundaram H, Putko BN, Tien J, D Ian Paterson, Bibiana Cujec, Jennifer R, et al. Hydroxychloroquine-induced cardiomyopathy: Case report, pathophysiology, diagnosis, and treatment. Can J Cardiol. 2014; 30: 1706-1715. DOI: 10.1016/j.cjca.2014.08.016
- Kuba K, Imai Y, Rao S, Hong G, Feng G, Bin G, et al. A crucial role of Angiotensin Converting Enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005; 11: 875-879. DOI: 10.1038/nm1267
- Yan R, Zhang Y, Li Y, Lu Xia, Qiang Zhou. Structure of dimeric full-length human ACE2 in complex with B0AT1 [J/OL]. BioRxiv. DOI: https://doi.org/10.1101/2020.02.17.951848
- Ferrario CM, Jessup J, Chappell MC, David BA, Bridget KB, Tallant E Ann, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005; 111: 2605-2610. DOI: 10.1161/CIRCULATIONAHA.104.510461
- Sun M, Yang J, Sun Y, Su GH. RAS inhibitors are one of the possible options for treating new coronavirus pneumonia. Chin J Tubere Respir Dis. 2020. DOI: 10.3760/cma.j.issn.1001-0939.2020.03.016
